Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 217,798,473 papers from all fields of science
Search
Sign In
Create Free Account
SUCLA2 gene
Known as:
A-BETA
, SUCCINATE-CoA LIGASE, ADP-FORMING, BETA SUBUNIT
, ATP-SPECIFIC SUCCINYL-CoA SYNTHETASE, BETA SUBUNIT
Expand
National Institutes of Health
Create Alert
Alert
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
2016
Review
2016
Succinate-CoA ligase deficiency due to mutations in SUCLA2 and SUCLG1: phenotype and genotype correlations in 71 patients
R. Carrozzo
,
D. Verrigni
,
+31 authors
E. Ostergaard
Journal of Inherited Metabolic Disease
2016
Corpus ID: 7881205
BackgroundThe encephalomyopathic mtDNA depletion syndrome with methylmalonic aciduria is associated with deficiency of succinate…
Expand
2016
2016
Two transgenic mouse models for β-subunit components of succinate-CoA ligase yielding pleiotropic metabolic alterations
Gergely Kacsó
,
Dora Ravasz
,
+19 authors
C. Chinopoulos
Biochemical Journal
2016
Corpus ID: 13377740
Succinate-CoA ligase (SUCL) is a heterodimer enzyme composed of Suclg1 α-subunit and a substrate-specific Sucla2 or Suclg2…
Expand
2016
2016
Knockdown of Sucla2 decreases the viability of mouse spermatocytes by inducing apoptosis through injury of the mitochondrial function of cells.
Shaoping Huang
,
Jing Wang
,
Lei Wang
Folia Histochemica et Cytobiologica
2016
Corpus ID: 34935045
INTRODUCTION Sucla2, a β subunit of succinyl coenzyme A synthase, is located in the mitochondrial matrix. Sucla2 catalyzes the…
Expand
Review
2014
Review
2014
Mitochondrial encephalomyopathy and retinoblastoma explained by compound heterozygosity of SUCLA2 point mutation and 13q14 deletion
Sanna Matilainen
,
P. Isohanni
,
+5 authors
A. Suomalainen
European Journal of Human Genetics
2014
Corpus ID: 11935896
Mutations in SUCLA2, encoding the ß-subunit of succinyl-CoA synthetase of Krebs cycle, are one cause of mitochondrial DNA…
Expand
Highly Cited
2011
Highly Cited
2011
The interplay between SUCLA2, SUCLG2, and mitochondrial DNA depletion.
Chaya Miller
,
Liya Wang
,
E. Ostergaard
,
P. Dan
,
Ann Saada
Biochimica et Biophysica Acta
2011
Corpus ID: 20990449
2009
2009
Dystonia and deafness due to SUCLA2 defect; Clinical course and biochemical markers in 16 children.
E. Morava
,
U. Steuerwald
,
+5 authors
R. Wevers
Mitochondrion (Amsterdam. Print)
2009
Corpus ID: 37125749
Review
2008
Review
2008
Inherited mitochondrial diseases of DNA replication.
W. Copeland
Annual Review of Medicine
2008
Corpus ID: 10436172
Mitochondrial genetic diseases can result from defects in mitochondrial DNA (mtDNA) in the form of deletions, point mutations, or…
Expand
Highly Cited
2007
Highly Cited
2007
SUCLA2 mutations are associated with mild methylmalonic aciduria, Leigh-like encephalomyopathy, dystonia and deafness.
R. Carrozzo
,
C. Dionisi-Vici
,
+16 authors
R. Wevers
Brain : a journal of neurology
2007
Corpus ID: 14957037
One pedigree with four patients has been recently described with mitochondrial DNA depletion and mutation in SUCLA2 gene leading…
Expand
Highly Cited
2007
Highly Cited
2007
Mitochondrial encephalomyopathy with elevated methylmalonic acid is caused by SUCLA2 mutations.
E. Ostergaard
,
F. Hansen
,
+8 authors
M. Schwartz
Brain : a journal of neurology
2007
Corpus ID: 3280166
We have identified 12 patients with autosomal recessive mitochondrial encephalomyopathy with elevated methylmalonic acid. The…
Expand
Highly Cited
2006
Highly Cited
2006
MPV17 encodes an inner mitochondrial membrane protein and is mutated in infantile hepatic mitochondrial DNA depletion
A. Spinazzola
,
C. Viscomi
,
+17 authors
M. Zeviani
Nature Genetics
2006
Corpus ID: 17999433
The mitochondrial (mt) DNA depletion syndromes (MDDS) are genetic disorders characterized by a severe, tissue-specific decrease…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE